Middle East and Africa Diabetes Care Devices Market Size - Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - Request a Free Sample

Middle East and Africa Diabetes Care Devices Market Overview

Diabetes care devices are playing an increasingly important role in improving disease monitoring and treatment through innovative technologies that support better long-term patient management. The market is growing due to rising diabetes prevalence and improving healthcare infrastructure. The market is poised to reach USD 6.75 Billion by 2035, driven by increasing government healthcare initiatives and expanding adoption of advanced diabetes management devices.

Middle East and Africa Diabetes Care Devices Market Growth Analysis and Key Influencers

Middle East and Africa Diabetes Care Devices Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Middle East and Africa Diabetes Care Devices Market Growth Drivers

Expanding Adoption of Advanced Diabetes Management Technologies is Strengthening the Market Value

The increasing adoption of advanced diabetes care technologies is supporting the expansion of the market by improving glucose management, treatment accuracy, and patient convenience. Automated insulin delivery systems, continuous glucose monitoring devices, and smart diabetes management are gaining wider acceptance across the region as healthcare providers prioritize better clinical outcomes. For instance, in February 2026, Insulet Corporation launched the Omnipod® 5 Automated Insulin Delivery System and Omnipod Discover™ in Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates, expanding access to advanced diabetes management technologies. This development is expected to accelerate technological adoption and strengthen the market's long-term growth.

Middle East and Africa Diabetes Care Devices Market Restraints

High Cost of Advanced Diabetes Care Devices Limits the Market Expansion

The high cost of advanced diabetes care devices, including continuous glucose monitoring systems, insulin pumps, and automated insulin delivery technologies, remains a significant challenge for the market. Limited reimbursement coverage in several countries, affordability concerns, and unequal access to specialized diabetes care reduce the adoption of innovative devices, particularly in lower-income populations. These factors restrict widespread utilization of advanced diabetes management solutions and continue to hinder the market's overall expansion.

Middle East and Africa Diabetes Care Devices Market Opportunities

Expansion of Digital Diabetes Management Platforms is Creating New Market Potential

The growing adoption of digital healthcare solutions is creating significant opportunities for the market by improving access to personalized diabetes management and remote patient support. Digital platforms that integrate continuous glucose monitoring, artificial intelligence, lifestyle coaching, and subscription-based care are enhancing patient engagement beyond clinical visits. For instance, in July 2026, DiabMart launched a comprehensive digital diabetes management platform in the United Arab Emirates, combining smart health technologies with personalized support and diabetes care products. Such developments are expected to expand digital diabetes care adoption and create new avenues for market growth.

Middle East and Africa Diabetes Care Devices Market Trends

The market is witnessing several trends, including artificial intelligence integration, wearable glucose monitoring, and digital diabetes management platforms.

Rising Adoption of Artificial Intelligence-Based Wearable Glucose Monitoring is Enhancing the Market Growth

Artificial intelligence-enabled wearable technologies are becoming an important trend in diabetes management by enabling non-invasive glucose monitoring, continuous health tracking, and improved patient convenience. For example, in July 2026, Qatar University announced the development of an artificial intelligence-powered wearable device designed to estimate blood glucose levels without finger-prick testing. Such innovations are expected to accelerate the adoption of advanced diabetes monitoring technologies and support sustained market growth.

Middle East and Africa Diabetes Care Devices Market Share

Type 2 Diabetes Segment is Expected to Hold the Largest Market Share by Disease Type

The market is segmented by disease type into type 1 diabetes and type 2 diabetes. Among these, type 2 diabetes is expected to lead due to its substantially higher disease burden, growing prevalence, and increasing demand for continuous glucose monitoring and insulin delivery devices. According to Jihad A. Haddad et al., 2025, the Middle East and North Africa region has the highest global prevalence of Type 2 diabetes at 16.2%, with the rate projected to increase significantly by 2045. This rising patient population is expected to sustain demand for advanced diabetes care devices and strengthen the market.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - Request a Free Sample

Middle East and Africa Diabetes Care Devices Market Analysis by Region

The regions covered in the report include Saudi Arabia, the United Arab Emirates, Nigeria, South Africa, and Others. Among these, Saudi Arabia is expected to lead due to its high diabetes prevalence, increasing adoption of artificial intelligence-enabled healthcare solutions, and supportive regulatory environment. For instance, in February 2025, Amplifai Health received Saudi Food and Drug Authority approval for TFscan, the world's first software as a medical device for diabetic foot screening using artificial intelligence and thermal imaging. Such advancements are expected to strengthen innovation, improve diabetes management, and reinforce the market's regional leadership.

Leading Players in the Middle East and Africa Diabetes Care Devices Market

Middle East and Africa Diabetes Care Devices Market Segmentation

Key Questions Answered in the Middle East and Africa Diabetes Care Devices Market Report

• What was the Middle East and Africa diabetes care devices market value in 2025?
• What is the Middle East and Africa diabetes care devices market forecast outlook for 2026-2035?
• What are the major factors aiding the Middle East and Africa diabetes care devices market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major diabetes care devices market trends?
• Which product type is expected to dominate the market segment?
• Which disease type is projected to lead the market segment?
• Which patient care setting is anticipated to drive the market segment?
• Who are the key players involved in the Middle East and Africa diabetes care devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

• Primary Research: In-depth interviews conducted with 30+ endocrinologists, diabetologists, diabetes educators, procurement managers, hospital administrators, and key opinion leaders (KOLs) across Saudi Arabia, the United Arab Emirates, South Africa, and other Middle East and Africa countries to assess market trends, technology adoption, reimbursement, and patient care practices.
• Secondary Research: Peer-reviewed publications from Diabetes Care, The Lancet Diabetes & Endocrinology, and the Journal of Diabetes Science and Technology; data from the World Health Organization (WHO), International Diabetes Federation (IDF), Ministries of Health, regulatory authorities, company annual reports, investor presentations, product catalogs, press releases, clinical studies, and official company websites.
• Validation: All quantitative estimates are triangulated using top-down and bottom-up market modeling techniques and validated through iterative expert review to ensure accuracy, consistency, and reliability.